These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 171985)

  • 21. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus.
    Wu P; Lee LF; Reed WM
    Avian Dis; 1997; 41(4):824-31. PubMed ID: 9454915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL; Sharma JM; Offenbecker L
    Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek's disease virus.
    Abdul-Careem MF; Haq K; Shanmuganathan S; Read LR; Schat KA; Heidari M; Sharif S
    Virology; 2009 Oct; 393(2):250-7. PubMed ID: 19733379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased susceptibility of leukemia-infected chickens to Marek's disease.
    Jakovleva LS; Mazurenko NP
    Neoplasma; 1979; 26(4):393-6. PubMed ID: 230419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of serotype 2 and 3 Marek's disease vaccines on the development of avian leukosis virus-induced pre-neoplastic bursal follicles.
    Marsh JD; Bacon LD; Fadly AM
    Avian Dis; 1995; 39(4):743-51. PubMed ID: 8719208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An enzyme-linked immunosorbent assay for the detection of antibodies to Marek's disease virus.
    Cheng YQ; Lee LF; Smith EJ; Witter RL
    Avian Dis; 1984; 28(4):900-11. PubMed ID: 6098254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications of immunodepression in chickens infected with various strains of Marek's disease virus.
    Rivas AL; Fabricant J
    Avian Dis; 1988; 32(1):1-8. PubMed ID: 2838012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural mechanisms of controlling lymphotropic herpesvirus infection (Marek's disease) in the chicken.
    Witter RL
    Cancer Res; 1976 Feb; 36(2 pt 2):681-7. PubMed ID: 175926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.
    Lesnik F; Ross LJ
    Int J Cancer; 1975 Jul; 16(1):153-63. PubMed ID: 170213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a monoclonal antibody against a nuclear antigen associated with serotype-1 Marek's disease virus-infected and transformed cells.
    Lee LF
    Avian Dis; 1993; 37(2):561-7. PubMed ID: 8395807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development.
    Sharma JM
    Avian Dis; 1987; 31(3):570-6. PubMed ID: 2823773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of levamisole on pathogenesis of Marek's disease.
    Kodama H; Mikami T; Izawa H
    J Natl Cancer Inst; 1980 Jul; 65(1):155-9. PubMed ID: 6248672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of a threshold of genetic resistance to Marek's disease and the incidence of humoral antibody.
    Sharma JM
    Avian Pathol; 1973 Apr; 2(2):75-90. PubMed ID: 18777387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.